[1] Violi NV, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial[J].Lancet Gastroenterol Hepatol,2018, 3(5): 317-325. [2] Serna S, Vilana R, Sánchez-Cabús S, et al. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment:A single European centre experience[J].HPB(Oxford),2015, 17(5): 387-393. [3] 宿敬存, 赵卫, 胡继红,等. TACE联合RFA及自体细胞因子诱导的杀伤细胞肝动脉灌注治疗原发性肝癌的临床研究[J].介入放射学杂志, 2017,16(1):24-29. [4] Wissniowski TT, Gress T, Di Fazio P. Long-term immune-modulatory side effects of radiofrequency ablation in patients with liver metastases and hepatocellular carcinoma[J].Hepatoma Res(Engl),2015, 1(2): 92-96. [5] Kim N, Yoo YC, Lee SK, et al. Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection[J].WJG,2015, 21(12): 3671. [6] 苏志辉. 持续输注右美托咪啶对丙泊酚复合瑞芬太尼静脉麻醉用药量的影响[J].中外医学研究, 2017, 15(1):33-34. [7] Rajan S, Hutcherson MT, Sessler DI, et al. The effects of dexmedetomidine and remifentanil on hemodynamic stability and analgesic requirement after craniotomy: a randomized controlled trial[J].J Neu Anes,2016, 28(4): 282-290. [8] 孙海涛, 许梅, 陈国莲,等. 右美托咪啶和瑞芬太尼用于肝肿瘤射频消融患者清醒镇静效果的临床观察[J].中华医学杂志, 2018,98(8):576-582. [9] Goettel N, Bharadwaj S, Venkatraghavan L, et al. Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial[J].Br J Aneasth,2016, 116(6): 811-821.
2020, Vol. 37 
